Profile data is unavailable for this security.
About the company
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
- Revenue in USD (TTM)96.63m
- Net income in USD-63.32m
- Incorporated2015
- Employees330.00
- LocationAkoya Biosciences Inc100 Campus Drive, 6Th FloorMARLBOROUGH 01762United StatesUSA
- Phone+1 (415) 765-6980
- Websitehttps://www.akoyabio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Electromed Inc | 51.69m | 3.94m | 152.31m | 170.00 | 39.36 | 3.77 | 32.73 | 2.95 | 0.4498 | 0.4498 | 5.91 | 4.69 | 1.17 | 2.95 | 2.27 | 304,076.50 | 8.91 | 7.86 | 10.39 | 9.14 | 76.51 | 76.25 | 7.62 | 7.38 | 5.25 | -- | 0.00 | 0.00 | 15.38 | 11.17 | 37.35 | 11.00 | 24.58 | -- |
| Clearpoint Neuro Inc | 23.96m | -22.09m | 160.79m | 107.00 | -- | 6.92 | -- | 6.71 | -0.8979 | -0.8979 | 0.9736 | 0.8589 | 0.4881 | 1.20 | 8.15 | 223,878.50 | -45.01 | -34.75 | -52.63 | -39.67 | 56.83 | 64.75 | -92.21 | -76.91 | 3.80 | -- | 0.3197 | -- | 16.56 | 26.64 | -34.40 | -- | 75.30 | -- |
| InfuSystem Holdings Inc | 125.79m | 872.00k | 165.23m | 499.00 | 196.06 | 3.15 | 12.30 | 1.31 | 0.0396 | 0.0396 | 5.86 | 2.47 | 1.24 | 11.17 | 6.85 | 252,074.10 | 0.8621 | 4.60 | 1.01 | 5.69 | 50.17 | 56.43 | 0.6933 | 4.07 | 1.54 | 1.88 | 0.3575 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
| Inogen Inc | 315.66m | -102.45m | 169.30m | 834.00 | -- | 0.8188 | -- | 0.5363 | -4.42 | -4.42 | 13.62 | 8.78 | 0.8634 | 6.76 | 6.01 | 378,489.20 | -28.02 | -8.23 | -34.53 | -9.53 | 40.14 | 44.54 | -32.46 | -10.31 | 2.56 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
| CVRx Inc | 42.09m | -52.01m | 172.12m | 200.00 | -- | 2.60 | -- | 4.09 | -2.48 | -2.48 | 2.01 | 3.07 | 0.3678 | 0.6781 | 5.64 | 210,430.00 | -45.45 | -- | -48.95 | -- | 84.45 | -- | -123.58 | -- | 10.87 | -21.11 | 0.3064 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
| Accuray Inc | 430.55m | -21.49m | 177.51m | 1.02k | -- | 4.32 | -- | 0.4123 | -0.2197 | -0.2197 | 4.42 | 0.4143 | 0.9178 | 1.86 | 5.72 | 420,462.90 | -4.58 | -1.45 | -7.84 | -2.48 | 33.06 | 37.86 | -4.99 | -1.62 | 0.778 | -0.4744 | 0.8086 | -- | 4.12 | 2.03 | -73.56 | -- | 13.92 | -- |
| Stereotaxis Inc | 26.77m | -22.06m | 184.79m | 122.00 | -- | 11.14 | -- | 6.90 | -0.2737 | -0.2737 | 0.3318 | 0.2708 | 0.5617 | 1.46 | 6.01 | 219,434.40 | -43.46 | -25.02 | -61.11 | -34.12 | 55.51 | 67.57 | -77.37 | -41.90 | 1.88 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| Orchestra Biomed Holdings Inc | 2.76m | -49.12m | 187.52m | 56.00 | -- | 2.76 | -- | 67.94 | -1.49 | -1.49 | 0.0832 | 1.90 | 0.0289 | 0.8815 | 28.31 | 49,285.71 | -51.49 | -- | -61.01 | -- | 93.26 | -- | -1,779.71 | -- | 7.94 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| Semler Scientific Inc | 68.18m | 20.58m | 194.55m | 92.00 | 10.53 | 2.65 | 9.18 | 2.85 | 2.63 | 2.63 | 8.71 | 10.43 | 0.9688 | 15.28 | 13.62 | 741,130.40 | 29.25 | 38.83 | 32.24 | 44.41 | 89.76 | 90.22 | 30.19 | 32.58 | 10.56 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| Outset Medical Inc | 130.38m | -172.80m | 195.95m | 480.00 | -- | 1.55 | -- | 1.50 | -3.49 | -3.49 | 2.64 | 2.44 | 0.3652 | 2.01 | 4.27 | 271,616.70 | -48.41 | -41.40 | -56.97 | -47.29 | 22.24 | 5.71 | -132.54 | -159.05 | 4.37 | -67.80 | 0.5143 | -- | 13.00 | 130.43 | -6.04 | -- | 14.27 | -- |
| Akoya Biosciences Inc | 96.63m | -63.32m | 203.28m | 330.00 | -- | 3.76 | -- | 2.10 | -1.48 | -1.48 | 2.18 | 1.09 | 0.5423 | 2.49 | 7.23 | 292,827.30 | -35.53 | -- | -44.59 | -- | 58.27 | -- | -65.53 | -- | 2.94 | -10.94 | 0.5882 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Butterfly Network Inc | 68.08m | -121.92m | 204.28m | 225.00 | -- | 1.00 | -- | 3.00 | -0.5893 | -0.5893 | 0.329 | 0.9685 | 0.2045 | 0.6954 | 4.97 | 302,577.80 | -36.61 | -- | -42.07 | -- | 26.50 | -- | -179.08 | -- | 3.34 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| AxoGen Inc | 163.73m | -21.28m | 247.80m | 426.00 | -- | 2.66 | -- | 1.51 | -0.4943 | -0.4943 | 3.80 | 2.13 | 0.8709 | 1.49 | 7.04 | 384,333.30 | -11.32 | -13.92 | -12.82 | -15.84 | 78.34 | 79.74 | -13.00 | -20.28 | 2.23 | -8.76 | 0.3346 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| AngioDynamics, Inc. | 324.01m | -192.37m | 248.34m | 815.00 | -- | 1.15 | -- | 0.7665 | -4.78 | -4.78 | 8.10 | 5.41 | 0.7468 | 2.66 | 6.46 | 397,555.80 | -44.34 | -9.12 | -54.02 | -10.17 | 50.17 | 54.23 | -59.37 | -19.48 | 1.62 | -- | 0.00 | -- | 7.13 | 5.30 | -97.54 | -- | 3.55 | -- |
| Utah Medical Products, Inc. | 50.22m | 16.64m | 249.04m | 169.00 | 15.17 | 1.96 | 10.85 | 4.96 | 4.57 | 4.57 | 13.81 | 35.35 | 0.3873 | 2.19 | 11.25 | 297,183.40 | 12.83 | 12.69 | 13.38 | 13.19 | 59.81 | 61.57 | 33.12 | 30.51 | 20.53 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
Data as of May 06 2024. Currency figures normalised to Akoya Biosciences Inc's reporting currency: US Dollar USD
24.84%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Blue Water Life Science Advisors LPas of 31 Dec 2023 | 4.70m | 9.56% |
| Polar Capital LLPas of 31 Dec 2023 | 1.58m | 3.22% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 1.36m | 2.78% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 1.22m | 2.49% |
| Parkman Healthcare Partners LLCas of 31 Dec 2023 | 674.79k | 1.37% |
| Uniplan Investment Counsel, Inc.as of 31 Dec 2023 | 673.52k | 1.37% |
| Stanford Management Co.as of 31 Dec 2023 | 620.43k | 1.26% |
| SVB Wealth LLCas of 31 Dec 2023 | 515.32k | 1.05% |
| Geode Capital Management LLCas of 31 Dec 2023 | 498.18k | 1.01% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 357.59k | 0.73% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
